logo-loader

'The best is yet to come' for Phivida Holdings, says President Belfontaine

Published: 11:18 01 May 2018 EDT

John Belfontaine, president and executive chairman of Phivida Holdings (CSE:VIDA), talks Proactive's Andrew Scott through the formation of the company and the management team which he describes as 'second-to-none'.

First trading as a public company in December 2017 they've moved quickly, securing deals with WeedMD Inc. (TSX-V:WMD) and Namaste Technologies Inc. ("Namaste") (CSE:N).

They've also just appointed Douglas Campbell as chief commercial officer. He brings with him extensive executive leadership, multi-channel marketing expertise and strong relationships with some of the largest food and beverage distributors and retailers in the world.

''Phivida has the brand, the product quality and standards necessary to cross over into the main stream'', Belfontaine says.

''We're excited about being in the pursuit of being that first crossover brand''.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

51 minutes ago